Cytokinetics (CYTK) Return on Equity: 2009-2025
Historic Return on Equity for Cytokinetics (CYTK) over the last 14 years, with Sep 2025 value amounting to 1.35%.
- Cytokinetics' Return on Equity rose 1320.00% to 1.35% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.35%, marking a year-over-year increase of 1320.00%. This contributed to the annual value of 2.20% for FY2024, which is 8.00% up from last year.
- According to the latest figures from Q3 2025, Cytokinetics' Return on Equity is 1.35%, which was down 25.09% from 1.81% recorded in Q2 2025.
- Cytokinetics' 5-year Return on Equity high stood at 7.69% for Q4 2024, and its period low was -11.85% during Q3 2024.
- Moreover, its 3-year median value for Return on Equity was 1.81% (2025), whereas its average is 1.26%.
- Per our database at Business Quant, Cytokinetics' Return on Equity crashed by 1,320bps in 2024 and then skyrocketed by 1,320bps in 2025.
- Quarterly analysis of 5 years shows Cytokinetics' Return on Equity stood at -0.82% in 2021, then spiked by 637bps to 5.55% in 2022, then slumped by 428bps to 1.27% in 2023, then surged by 642bps to 7.69% in 2024, then spiked by 1,320bps to 1.35% in 2025.
- Its Return on Equity was 1.35% in Q3 2025, compared to 1.81% in Q2 2025 and 2.97% in Q1 2025.